trending Market Intelligence /marketintelligence/en/news-insights/trending/qbtk1jgpk4ioboyo1uqhyq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

UK court backs Boston Scientific claims in patent case vs Edwards Lifesciences

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


UK court backs Boston Scientific claims in patent case vs Edwards Lifesciences

The U.K. Court of Appeal ruled in favor of Boston Scientific Corp. in a patent infringement case against Edwards Lifesciences Corp.

The British court dismissed an appeal by Edwards Lifesciences and upheld a March 2017 court ruling that Edwards Lifesciences' Sapien 3 transcatheter heart valve infringed on a Boston Scientific patent and that all claims of that patent are valid.

The U.S. Patent and Trademark Office previously favored in favor of Edwards Lifesciences earlier in March 2018 in an inter partes review of Boston Scientific's claims regarding its transcatheter heart valve.

Boston Scientific plans to appeal the patent agency's finding.

Marlborough, Mass.-based Boston Scientific had filed a patent case against Irvine, Calif.-based Edwards Lifesciences in Delaware in 2016.